Free Trial

Pliant Therapeutics (PLRX) SEC Filings & 10K Form

Pliant Therapeutics logo
$12.43 -0.42 (-3.27%)
(As of 11/15/2024 ET)

Recent Pliant Therapeutics SEC Filings

DateFilerForm TypeView
11/14/2024
8:00 PM
Pliant Therapeutics (Subject)
Redmile Group, LLC (Filed by)
Form SC 13G
11/12/2024
10:53 AM
Laurion Capital Management LP (Filed by)
Pliant Therapeutics (Subject)
Form SC 13G/A
10/04/2024
4:34 PM
Paradigm Biocapital Advisors LP (Filed by)
Pliant Therapeutics (Subject)
Form SC 13G
09/27/2024
3:11 PM
Pliant Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/07/2024
3:13 PM
Pliant Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/15/2024
10:54 AM
Pliant Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2024
5:37 PM
Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
5:41 PM
Hull Hans (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
5:45 PM
Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
5:15 PM
Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/12/2024
5:22 PM
Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
4:01 PM
Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
3:47 PM
Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
3:54 PM
Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
3:41 PM
Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:15 PM
Curnutte John T (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:15 PM
Bruhn Suzanne Louise (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:15 PM
CROWELL GAYLE A (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:15 PM
Cline Darren S (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:15 PM
Pliant Therapeutics (Issuer)
Shah Smital (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:16 PM
Pliant Therapeutics (Issuer)
PYOTT DAVID E I (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:16 PM
Huh Hoyoung (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:16 PM
Knobil Katharine (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
7:16 PM
MCCOURT Thomas A (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:57 PM
Krognes Steve E. (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/17/2024
6:52 PM
Krognes Steve E. (Reporting)
Pliant Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
05/14/2024
6:43 AM
Pliant Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2024
3:27 PM
Pliant Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2024
5:02 AM
Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/12/2024
6:45 AM
Pliant Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2024
3:20 PM
Pliant Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/14/2024
7:55 PM
Blue Owl Capital Holdings LP (Filed by)
Pliant Therapeutics (Subject)
Form SC 13G
02/14/2024
4:10 PM
First Light Asset Management, LLC (Filed by)
Pliant Therapeutics (Subject)
Form SC 13G
02/14/2024
7:52 AM
Deep Track Capital, LP (Filed by)
Pliant Therapeutics (Subject)
Form SC 13G/A
02/09/2024
8:28 AM
FMR LLC (Filed by)
Pliant Therapeutics (Subject)
Form SC 13G/A
02/08/2024
11:29 AM
Laurion Capital Management LP (Filed by)
Pliant Therapeutics (Subject)
Form SC 13G
02/05/2024
6:31 AM
Pliant Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/25/2024
3:59 PM
BlackRock Inc. (Filed by)
Pliant Therapeutics (Subject)
Form SC 13G
01/24/2024
3:56 PM
Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
4:18 PM
Lefebvre Eric (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
4:19 PM
Coulie Bernard (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
2024's Must-Watch Stocks! (Ad)

Welcome to a year of unparalleled opportunities! Dive into our exclusive guide, "9 Stocks Set to Soar," meticulously selected to elevate your portfolio in 2024. Step into 2024 with confidence and the right assets at your fingertips. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.

01/19/2024
4:19 PM
Hull Hans (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
4:19 PM
Cummings Keith Lamont (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
4:11 PM
Ouimette Mike (Reporting)
Pliant Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:PLRX) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners